Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC4 | P56524 | 1/20 | 0.67 |
| ▸ | HSD11B1 | P28845 | 4/20 | 0.54 |
| ▸ | AVPR1A | P37288 | 4/20 | 0.53 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.51 |
| ▸ | IDO1 | P14902 | 1/20 | 0.51 |
| ▸ | FFAR2 | O15552 | 2/20 | 0.49 |
| ▸ | CCR8 | P51685 | 1/20 | 0.48 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25464152 | 0.98 | HDAC4 (0.65) | HDAC4HSD11B1AVPR1AHDAC1LMNA | |
| SCHEMBL25464161 | 0.95 | HDAC4 (0.65) | HDAC4HSD11B1AVPR1AHDAC1ALDH1A1 | |
| SCHEMBL4961970 | 0.89 | POLB (0.57) | HDAC4HSD11B1AVPR1AALDH1A1IDO1 | |
| SCHEMBL4964872 | 0.88 | HDAC4 (0.51) | HDAC4HSD11B1AVPR1ALMNAIDO1 | |
| SCHEMBL25464156 | 0.87 | IDO1 (0.54) | HDAC4HSD11B1AVPR1ALMNAALDH1A1 | |
| SCHEMBL3517801 | 0.82 | SLC6A4 (0.56) | HDAC4HDAC1ALDH1A1IDO1CCR8 | |
| SCHEMBL25464568 | 0.82 | IDO1 (0.55) | HDAC4LMNAALDH1A1IDO1CCR8 | |
| Hydrochloric Acid SCHEMBL4000831 | 0.82 | HDAC4 (0.52) | HDAC4HSD11B1AVPR1AHDAC1ALDH1A1 | |
| SCHEMBL16132869 | 0.80 | HDAC4 (1.00) | HDAC4HSD11B1HDAC1ALDH1A1FFAR2 | |
| SCHEMBL25464360 | 0.80 | AVPR1A (0.55) | HDAC4AVPR1ALMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230151074-A1 | MODULATORS OF G-PROTEIN COUPLED RECEPTORS | CARMOT THERAPEUTICS, INC. | 2023-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230151074-A1 | MODULATORS OF G-PROTEIN COUPLED RECEPTORS | GIPR, GLP1R, GCGR | HDAC4 2192/4885HSD11B1 2569/4885AVPR1A 198/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.